The Role of Cortisol and Dehydroepiandrosterone in Obesity, Pain, and Aging
Diseases,
Год журнала:
2025,
Номер
13(2), С. 42 - 42
Опубликована: Фев. 1, 2025
Obesity,
chronic
pain,
and
aging
are
prevalent
global
challenges
with
profound
implications
for
health
well-being.
Central
to
these
processes
adrenal
hormones,
particularly
cortisol
dehydroepiandrosterone
(DHEA),
along
its
sulfated
form
(DHEAS).
Cortisol,
essential
stress
adaptation,
can
have
adverse
effects
on
pain
perception
when
dysregulated,
while
DHEA/S
possess
properties
that
may
mitigate
effects.
This
review
explores
the
roles
of
in
contexts
obesity,
acute
aging,
age-related
diseases.
We
examine
hormonal
balance,
specifically
cortisol-to-DHEA
ratio
(CDR),
as
a
key
marker
system
functionality
impact
sensitivity,
neurodegeneration,
physical
decline.
Elevated
CDR
decreased
levels
associated
worsened
outcomes,
including
increased
frailty,
immune
dysfunction,
progression
conditions
such
osteoporosis
Alzheimer’s
disease.
synthesizes
current
literature
highlight
complex
interplay
between
hormones
their
broader
health.
It
aims
provide
insights
into
potential
future
therapies
improve
management
promote
healthy
weight
aging.
By
investigating
mechanisms,
this
work
contributes
deeper
understanding
physiological
intersections
endocrine
system.
Язык: Английский
The Role of Mitochondrial Copy Number in Neurodegenerative Diseases: Present Insights and Future Directions
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(11), С. 6062 - 6062
Опубликована: Май 31, 2024
Neurodegenerative
diseases
are
progressive
disorders
that
affect
the
central
nervous
system
(CNS)
and
represent
major
cause
of
premature
death
in
elderly.
One
possible
determinants
neurodegeneration
is
change
mitochondrial
function
content.
Altered
levels
DNA
copy
number
(mtDNA-CN)
biological
fluids
have
been
reported
during
both
early
stages
progression
diseases.
In
patients
affected
by
neurodegenerative
diseases,
changes
mtDNA-CN
appear
to
correlate
with
dysfunction,
cognitive
decline,
disease
progression,
ultimately
therapeutic
interventions.
this
review,
we
report
main
results
published
up
April
2024,
regarding
evaluation
blood
samples
from
Alzheimer’s
(AD),
Parkinson’s
(PD),
Huntington’s
(HD),
amyotrophic
lateral
sclerosis
(ALS),
multiple
(MS).
The
aim
show
a
probable
link
between
disorders.
Understanding
causes
underlying
association
could
provide
useful
information
on
molecular
mechanisms
involved
offer
development
new
diagnostic
approaches
Язык: Английский
Network pharmacology-based approach to investigate the molecular targets and molecular mechanisms of Rosmarinus officinalis L. for treating aging-related disorders
Biogerontology,
Год журнала:
2024,
Номер
25(5), С. 793 - 808
Опубликована: Июль 17, 2024
Язык: Английский
Neuropharmacology of endophytic fungal bioactives: Promising leads for brain disorders
Elsevier eBooks,
Год журнала:
2025,
Номер
unknown, С. 109 - 132
Опубликована: Янв. 1, 2025
Язык: Английский
Inflammaging: The Next Challenge—Exploring the Role of Gut Microbiota, Environmental Factors, and Sex Differences
Biomedicines,
Год журнала:
2024,
Номер
12(8), С. 1716 - 1716
Опубликована: Авг. 1, 2024
The
term
'inflammaging'
has
been
coined
to
describe
the
chronic
state
of
inflammation
derived
from
ongoing
cycles
tissue
damage
and
subsequent
immune
responses.
This
inflammatory
status
contributes
decline
organs
physiological
functions,
accelerates
aging
process,
increases
risk
age-related
illnesses
death.
During
aging,
gut
microbiota
(GM)
undergoes
significant
changes,
including
a
decreased
diversity
species,
in
beneficial
bacteria,
rise
proinflammatory
ones,
resulting
persistent
low-grade
inflammation.
Moreover,
environmental
factors,
such
as
diet
medications,
contribute
changes
GM
function,
preventing
or
promoting
inflammaging.
narrative
review
aims
clarify
underlying
mechanisms
inflammaging
specifically
investigate
influence
several
factors
on
these
mechanisms,
while
also
exploring
potential
differences
related
sex.
lifestyle
pharmacological
interventions
will
be
suggested
promote
healthy
aging.
Язык: Английский
Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives
Frontiers in Aging,
Год журнала:
2024,
Номер
5
Опубликована: Окт. 17, 2024
Growth
and
aging
are
fundamental
elements
of
human
development.
Aging
is
defined
by
a
decrease
in
physiological
activities
higher
illness
vulnerability.
Affected
lifestyle,
environmental,
hereditary
elements,
results
disorders
including
cardiovascular,
musculoskeletal,
neurological
diseases,
which
accounted
for
16.1
million
worldwide
deaths
2019.
Stress-induced
cellular
senescence,
caused
DNA
damage,
can
reduce
tissue
regeneration
repair,
promoting
aging.
The
root
cause
many
age-related
inflammation,
encouraged
the
senescence-associated
secretory
phenotype
(SASP).
Aging's
metabolic
changes
declining
immune
systems
raise
risk
via
microbiome
diversity.
Stable,
individual-specific
skin
oral
microbiomes
essential
both
health
disease
since
dysbiosis
linked
with
periodontitis
eczema.
Present
from
birth
to
death,
microbiome,
under
influence
diet
interacts
symbiotically
body.
Poor
dental
has
been
Alzheimer's
Parkinson's
diseases
microorganisms
systemic
have
important
interactions.
Emphasizing
importance
across
lifetime,
this
study
reviews
understanding
microbiome's
role
aging-related
that
direct
novel
diagnosis
treatment
approaches.
Язык: Английский
Aging-induced dysbiosis worsens sepsis severity but is attenuated by probiotics in D-galactose-administered mice with cecal ligation and puncture model
PLoS ONE,
Год журнала:
2024,
Номер
19(10), С. e0311774 - e0311774
Опубликована: Окт. 18, 2024
Introduction
Despite
the
well-established
effects
of
aging
on
brain
function
and
gut
dysbiosis
(an
imbalance
in
microbiota),
influence
sepsis-associated
encephalopathy
(SAE)
role
probiotics
this
context
remain
less
understood.
Methods
C57BL/6J
mice
(8-week-old)
were
subcutaneously
administered
with
8
weeks
D-galactose
(D-gal)
or
phosphate
buffer
solution
(PBS)
for
non-aging
models,
respectively,
without
oral
Lacticaseibacillus
rhamnosus
GG
(LGG).
Additionally,
impact
condition
media
from
LGG
(LCM)
was
tested
macrophages
(RAW
264.7
cells),
microglia
(BV-2
hippocampal
cells
(HT-22
cells).
Result
Fecal
microbiome
analysis
demonstrated
D-gal-induced
(reduced
Firmicutes
Desulfobacterota
increased
Bacteroidota
Verrucomicrobiota),
which
partially
neutralized
dysbiosis.
D-gal
also
worsens
cecal
ligation
puncture
(CLP)
sepsis
severity
when
compared
PBS-CLP
mice,
as
indicated
by
serum
creatinine
(Scr)
alanine
transaminase
(ALT),
but
not
mortality,
neurological
characteristics
(SHIRPA
score),
cytokines
(TNF-α
IL-6).
supported
fibrosis
liver,
kidney,
lung;
however,
CLP
did
worsen
fibrosis.
Interestingly,
attenuated
all
parameters
(mortality,
Scr,
ALT,
SHIRPA,
cytokines)
(PBS-CLP)
while
improving
these
parameters,
except
mortality
IL-6,
(D-gal
CLP).
For
vitro
test
using
lipopolysaccharide
(LPS)
stimulation,
LCM
inflammation
some
RAW264.7
BV-2
HT-22
cells,
implying
a
direct
anti-inflammatory
effect
macrophages,
brain.
Conclusion
induced
fecal
worsened
determined
Scr
could
alleviate
most
selected
sepsis,
including
SAE.
However,
SAE
delivery
beneficial
molecules
to
partly
due
attenuation
systemic
through
modulation
macrophages.
Язык: Английский
From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications
Cells,
Год журнала:
2024,
Номер
13(24), С. 2052 - 2052
Опубликована: Дек. 12, 2024
Cellular
rejuvenation
therapies
represent
a
transformative
frontier
in
addressing
age-related
decline
and
extending
human
health
span.
By
targeting
fundamental
hallmarks
of
aging—such
as
genomic
instability,
epigenetic
alterations,
mitochondrial
dysfunction,
cellular
senescence—these
aim
to
restore
youthful
functionality
cells
tissues,
offering
new
hope
for
treating
degenerative
diseases.
Recent
advancements
have
showcased
range
strategies,
including
reprogramming,
senolytic
interventions,
restoration,
stem
cell-based
approaches,
gene-editing
technologies
like
CRISPR.
Each
modality
has
demonstrated
substantial
potential
preclinical
models
is
now
being
cautiously
explored
early-stage
clinical
trials.
However,
translating
these
from
the
laboratory
practice
presents
unique
challenges:
safety
concerns,
delivery
precision,
complex
regulatory
requirements,
ethical
considerations,
high
costs
impede
widespread
adoption.
This
review
examines
current
landscape
rejuvenation,
highlighting
key
advancements,
risks,
strategies
needed
overcome
hurdles.
Язык: Английский
Spectral graph convolutional neural network for Alzheimer's disease diagnosis and multi-disease categorization from functional brain changes in magnetic resonance images
Frontiers in Neuroinformatics,
Год журнала:
2024,
Номер
18
Опубликована: Окт. 30, 2024
Alzheimer's
disease
(AD)
is
a
progressive
neurological
disorder
characterized
by
the
gradual
deterioration
of
cognitive
functions,
leading
to
dementia
and
significantly
impacting
quality
life
for
millions
people
worldwide.
Early
accurate
diagnosis
crucial
effective
management
treatment
this
debilitating
condition.
This
study
introduces
novel
framework
based
on
Spectral
Graph
Convolutional
Neural
Networks
(SGCNN)
diagnosing
AD
categorizing
multiple
diseases
through
analysis
functional
changes
in
brain
structures
captured
via
magnetic
resonance
imaging
(MRI).
To
assess
effectiveness
our
approach,
we
systematically
analyze
structural
modifications
SGCNN
model
comprehensive
ablation
studies.
The
performance
various
(CNNs)
also
evaluated,
including
variants,
Base
CNN,
Lean
Deep
CNN.
We
begin
with
original
model,
which
serves
as
baseline
achieves
commendable
classification
accuracy
93%.
In
investigation,
perform
two
distinct
studies
examine
how
specific
impact
its
performance.
results
reveal
that
Ablation
Model
1
enhances
accuracy,
achieving
an
impressive
95%,
while
2
maintains
Additionally,
CNN
demonstrates
strong
93%,
whereas
both
models
achieve
94%
indicating
their
competitive
capabilities.
validate
models'
effectiveness,
utilize
evaluation
metrics,
precision,
recall,
F1-score,
ensuring
thorough
assessment
Our
findings
underscore
(SGCNN
1)
delivers
highest
predictive
among
tested
models,
highlighting
potential
robust
approach
image
classification.
Ultimately,
research
aims
facilitate
early
AD,
contributing
improved
patient
outcomes
advancing
field
neurodegenerative
diagnosis.
Язык: Английский